TherapeuticsMD Inc reports results for the quarter ended in June - Earnings Summary

TherapeuticsMD

15/08/2022 14:31

* TherapeuticsMD Inc  TXMD.OQ  reported quarterly adjusted
earnings of $12.39​​ per share for the quarter ended in June.
The lone analyst forecast for the quarter was for a loss of
$3.04 per share.
    * Revenue rose 24.2% to $28.56 million from a year ago;
analysts
expected $23.20 million. 
    * TherapeuticsMD Inc's reported EPS for the quarter was
$12.39​.
    * The mean earnings estimate of analysts had fallen by
about 26.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had fallen by 7.4% this
quarter and
lost 48.2% so far this year.
    * The company reported quarterly net income of $112.28
million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -3.04          12.39          Beat
 Mar. 31 2022      -4.00          -5.69          Missed
 Dec. 31 2021      -3.83          -5.00          Missed
 Sep. 30 2021      -5.00          -5.50          Missed